Literature DB >> 17687095

Biomarkers in COPD: time for a deep breath.

R A Stockley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17687095      PMCID： PMC2117266          DOI： 10.1136/thx.2007.084228

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  22 in total

Review 1.  Neutrophils and protease/antiprotease imbalance.

Authors:  R A Stockley
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

2.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.

Authors:  Charlotte E Bolton; Alina A Ionescu; Kathleen M Shiels; Rebecca J Pettit; Peter H Edwards; Michael D Stone; Lisette S Nixon; William D Evans; Timothy L Griffiths; Dennis J Shale
Journal:  Am J Respir Crit Care Med       Date:  2004-09-16       Impact factor: 21.405

3.  Systemic inflammation and decline in lung function in a general population: a prospective study.

Authors:  Andrew W Fogarty; Stuart Jones; John R Britton; Sarah A Lewis; Tricia M McKeever
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

4.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Authors:  Paul M Ridker; Nader Rifai; Lynda Rose; Julie E Buring; Nancy R Cook
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

5.  Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study.

Authors:  Walter Gianni; Andrea Ricci; Paola Gazzaniga; Marina Brama; Maria Pietropaolo; Sergio Votano; Francesco Patanè; Anna Maria Aglianò; Giovanni Spera; Vincenzo Marigliano; Sergio Ammendola; Donato Agnusdei; Silvia Migliaccio; Roberto Scandurra
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

6.  Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women.

Authors:  Jamal S Rana; Murray A Mittleman; Javed Sheikh; Frank B Hu; JoAnn E Manson; Graham A Colditz; Frank E Speizer; R Graham Barr; Carlos A Camargo
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

7.  IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.

Authors:  G S Hotamisligil; P Peraldi; A Budavari; R Ellis; M F White; B M Spiegelman
Journal:  Science       Date:  1996-02-02       Impact factor: 47.728

8.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha.

Authors:  Y P Li; R J Schwartz; I D Waddell; B R Holloway; M B Reid
Journal:  FASEB J       Date:  1998-07       Impact factor: 5.191

9.  Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse.

Authors:  Andrew Churg; Rong D Wang; Hsin Tai; Xiaoshan Wang; Changshi Xie; Joanne L Wright
Journal:  Am J Respir Crit Care Med       Date:  2004-06-07       Impact factor: 21.405

10.  Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways.

Authors:  C E H Stewart; P V Newcomb; J M P Holly
Journal:  J Cell Physiol       Date:  2004-02       Impact factor: 6.384
View more
  6 in total

1.  Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.

Authors:  F Gulli; C Napodano; M Marino; G Ciasca; K Pocino; V Basile; M Visentini; A Stefanile; L Todi; M De Spirito; G L Rapaccini; U Basile
Journal:  Clin Exp Immunol       Date:  2019-10-31       Impact factor: 4.330

Review 2.  Defining phenotypes in COPD: an aid to personalized healthcare.

Authors:  Andrea Segreti; Emanuele Stirpe; Paola Rogliani; Mario Cazzola
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

3.  Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner.

Authors:  Chi-Huei Chiang; Chiao-Hui Chuang; Shiou-Ling Liu
Journal:  Lung       Date:  2013-10-24       Impact factor: 2.584

Review 4.  The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Authors:  Tracy J Doyle; Victor Pinto-Plata; Danielle Morse; Bartolome R Celli; Ivan O Rosas
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

5.  Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.

Authors:  Theodore A Omachi; Mark D Eisner; Alexis Rames; Lada Markovtsova; Paul D Blanc
Journal:  Respir Res       Date:  2011-03-23

6.  Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD.

Authors:  Victor Pinto-Plata; Ciro Casanova; Hana Müllerova; Juan P de Torres; Henneth Corado; Nerea Varo; Elizabeth Cordoba; Salah Zeineldine; Hildegarde Paz; Rebeca Baz; Miguel Divo; Felipe Cortopassi; Bartolome R Celli
Journal:  Respir Res       Date:  2012-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.